PRE HOLDING, INC.

PARI Medical Holding is a German medical technology company founded in 1906, headquartered in Starnberg, and employs 500–750 people. The company is the global market leader in inhalation therapy devices and the world leader in cystic fibrosis treatment solutions. PARI specializes in manufacturing nebulizers and aerosol therapy systems for chronic and acute respiratory diseases including COPD, asthma, cystic fibrosis, bronchitis, sinusitis, and bronchiolitis. Core products include the flagship PARI BOY® nebulizer (marketed for over 50 years), PARI COMPACT2, PARI BOY variants (Junior, Classic, Pro), VELOX portable nebulizer, and PARI SINUS2 for sinusitis treatment. The company's eFlow® Technology platform delivers advanced vibrating membrane nebulizers optimized for specific pharmaceutical applications. PARI Pharma collaborates with pharmaceutical partners to develop drug-device combination products and provides clinical trial support. All core products are manufactured in-house in Germany, emphasizing quality control and reliability. The company serves patients, families, and healthcare professionals globally through both B2B pharmaceutical partnerships and direct-to-patient channels.